Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic
- 23 December 2020
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 44 (3) , 847-849
Abstract
OBJECTIVE: Real-time continuous glucose monitoring (rtCGM) in critically ill hospitalized patients holds promise; however, real-world data are needed. RESEARCH DESIGN AND METHODS: We placed Dexcom G6 CGM on intensive care unit (ICU) patients at Montefiore Medical Center with confirmed coronavirus disease 2019 (COVID-19) infection and glycemic variability. We analyzed inpatient CGM accuracy using point-of-care (POC) glucose–CGM matched pairs and included patients for analysis regardless of clinical status. RESULTS: We included 11 patients with CGM: 8 on continuous insulin infusion (CII), 8 on vasopressors, 8 intubated, 4 on high-dose glucocorticoids, 6 on renal replacement therapy, and 2 with anasarca. Accuracy was 12.58% for mean and 6.3% for median absolute relative difference. CGM reduced POC testing by ∼60% for patients on CII. CONCLUSIONS: In this real-world preliminary analysis of rtCGM during critical illness, we demonstrate early feasibility, considerable accuracy, and meaningful reduction in the frequency of POC glucose testing.Keywords
This publication has 14 references indexed in Scilit:
- Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 PandemicJournal of Diabetes Science and Technology, 2020
- Performance of a factory‐calibrated, real‐time continuous glucose monitoring system during elective abdominal surgeryDiabetes, Obesity and Metabolism, 2020
- Remote Glucose Monitoring of Hospitalized, Quarantined Patients With Diabetes and COVID-19Diabetes Care, 2020
- A Pilot Study of the Feasibility and Accuracy of Inpatient Continuous Glucose MonitoringDiabetes Care, 2020
- Individualizing Inpatient Diabetes Management During the Coronavirus Disease 2019 PandemicJournal of Diabetes Science and Technology, 2020
- Diabetes Technology in the Inpatient Setting for Management of HyperglycemiaEndocrinology and Metabolism Clinics of North America, 2020
- Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring DevicesJournal of Diabetes Science and Technology, 2018
- Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor ApplicatorDiabetes Technology & Therapeutics, 2018
- A New Era in Continuous Glucose Monitoring: Food and Drug Administration Creates a New Category of Factory-Calibrated Nonadjunctive, Interoperable Class II Medical DevicesDiabetes Technology & Therapeutics, 2018
- Statistical Tools to Analyze Continuous Glucose Monitor DataDiabetes Technology & Therapeutics, 2009